These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23261076)

  • 21. Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma.
    Kars M; Delgado V; Holman ER; Feelders RA; Smit JW; Romijn JA; Bax JJ; Pereira AM
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3348-56. PubMed ID: 18559921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
    Dhanwal DK; Sharma AK
    Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.
    Hamidianjahromi A; Tritos NA
    Rev Endocr Metab Disord; 2022 Oct; 23(5):1089-1099. PubMed ID: 36125673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study.
    Dogansen SC; Cikrikcili U; Oruk G; Kutbay NO; Tanrikulu S; Hekimsoy Z; Hadzalic A; Gorar S; Omma T; Mert M; Akbaba G; Yalin GY; Bayram F; Ozkan M; Yarman S
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2527-2534. PubMed ID: 30848825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma.
    Bulwer C; Conn R; Shankar A; Ferrau F; Kapur S; Ederies A; Korbonits M; Spoudeas HA
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):862-864. PubMed ID: 28346715
    [No Abstract]   [Full Text] [Related]  

  • 26. Pregnancy and Tumor Outcomes in Women with Prolactinoma.
    Araujo B; Belo S; Carvalho D
    Exp Clin Endocrinol Diabetes; 2017 Nov; 125(10):642-648. PubMed ID: 28704852
    [No Abstract]   [Full Text] [Related]  

  • 27. Late development of resistance to bromocriptine in a patient with macroprolactinoma.
    Delgrange E; Crabbé J; Donckier J
    Horm Res; 1998; 49(5):250-3. PubMed ID: 9568811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.
    Di Sarno A; Landi ML; Marzullo P; Di Somma C; Pivonello R; Cerbone G; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):53-60. PubMed ID: 10931080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required.
    Kars M; Pereira AM; Bax JJ; Romijn JA
    Eur J Endocrinol; 2008 Oct; 159(4):363-7. PubMed ID: 18703568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?
    Papanastasiou L; Fountoulakis S; Pappa T; Liberopoulos K; Malliopoulos D; Markou A; Piaditis G
    Hormones (Athens); 2014; 13(2):290-5. PubMed ID: 24776630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma.
    Howell DL; Wasilewski K; Mazewski CM; Hudgins RJ; Meacham LR
    J Pediatr Hematol Oncol; 2005 Jun; 27(6):326-9. PubMed ID: 15956887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data.
    Caputo C; Prior D; Inder WJ
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):906-13. PubMed ID: 25466526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid (CSF) rhinorrhoea occurring six days after commencement of bromocriptine for invasive macroprolactinoma.
    Hewage UC; Colman PG; Kaye A
    Aust N Z J Med; 2000 Jun; 30(3):399-400. PubMed ID: 10914763
    [No Abstract]   [Full Text] [Related]  

  • 34. Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis.
    Hu J; Zheng X; Zhang W; Yang H
    Pituitary; 2015 Oct; 18(5):745-51. PubMed ID: 25500765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to manage intolerance to dopamine agonist in patients with prolactinoma.
    Stumpf MAM; Pinheiro FMM; Silva GO; Cescato VAS; Musolino NRC; Cunha-Neto MBC; Glezer A
    Pituitary; 2023 Apr; 26(2):187-196. PubMed ID: 37027090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of iatrogenic severe mitral regurgitation.
    D'Aloia A; Piovanelli B; Rovetta R; Bonadei I; Vizzardi E; Curnis A; Metra M
    Monaldi Arch Chest Dis; 2013 Sep; 80(3):133-6. PubMed ID: 24818320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid leakage as complication of treatment with cabergoline for macroprolactinomas.
    Netea-Maier RT; van Lindert EJ; Timmers H; Schakenraad EL; Grotenhuis JA; Hermus AR
    J Endocrinol Invest; 2006 Dec; 29(11):1001-5. PubMed ID: 17259798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type.
    Bolko P; Jaskuła M; Waśko R; Wołuń M; Sowiński J
    Pol Arch Med Wewn; 2003 May; 109(5):489-95. PubMed ID: 14768178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma.
    Gürbüz F; Yağcı-Küpeli B; Kör Y; Yüksel B; Zorludemir S; Gürbüz BB; Küpeli S
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):159-63. PubMed ID: 23945126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas.
    Martinkova J; Trejbalova L; Sasikova M; Benetin J; Valkovic P
    Clin Neuropharmacol; 2011; 34(5):179-81. PubMed ID: 21738024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.